Methylergometrine is used in the prophylaxis of which of the following conditions?
A pregnant female has a past history of embolism in puerperium. What medical management should she take in her next pregnancy to avoid recurrence?
A new mother presents 8 days after a cesarean section with a fever of 101.4°F. On examination, her uterus is soft and extremely tender. Puerperal infection is confirmed. What is the most likely diagnosis?
A nursing mother presented with fever and breast tenderness two weeks postpartum. Which oral antibiotic is ideal for her condition?
A 26-year-old female presents with postpartum hemorrhage on her second postnatal day. Her activated partial thromboplastin time (APTT) is prolonged, while bleeding time, prothrombin time, and platelet count are normal. What is the likely diagnosis?
Puerperal sepsis is due to the spread of infection along which route?
A 24-year-old woman, 10 days postpartum, presents with increasing right breast pain, swelling, redness, and warmth, accompanied by a temperature of 38.3°C. She reports difficulty with her infant's latch and a cracked nipple. Examination reveals a warm, swollen, red, and tender right nipple and areola, with no fluctuance or induration. What is the recommended management?
Anti-D immunoglobulin should be administered following Rh+ delivery within what timeframe?
What is the most common site of puerperal infection?
Galactokinesis means:
Explanation: **Explanation:** **Methylergometrine** is a semi-synthetic ergot alkaloid that acts as a potent **uterotonic agent**. It works by directly stimulating the smooth muscles of the uterus, causing sustained (tetanic) contractions. This mechanical compression of the intramyometrial blood vessels (the "physiologic ligatures") effectively controls bleeding from the placental site, making it a primary drug for the **prophylaxis and management of Postpartum Hemorrhage (PPH)**. **Analysis of Options:** * **Option B (Correct):** It is routinely used in the active management of the third stage of labor (AMTSL) to prevent atonic PPH. * **Option A (Incorrect):** While other ergot alkaloids like *Ergotamine* are used for Migraine, Methylergometrine is specifically used for its uterine effects. * **Option C (Incorrect):** Methylergometrine is **strictly contraindicated** in Pregnancy-induced hypertension (PIH) and Eclampsia. It has alpha-adrenergic effects that cause peripheral vasoconstriction, which can lead to a dangerous spike in blood pressure and potential encephalopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Route & Dose:** Usually administered as 0.2 mg Intramuscularly (IM). The intravenous (IV) route is avoided due to the risk of sudden hypertension and stroke. * **Contraindications:** Hypertension, Preeclampsia, Heart disease (due to coronary vasospasm), and peripheral vascular disease. * **Mechanism:** It acts on alpha-adrenergic, serotonergic, and dopaminergic receptors. * **Storage:** It is light-sensitive and should be stored in a cool, dark place (often in amber-colored ampoules).
Explanation: **Explanation:** The risk of venous thromboembolism (VTE) is significantly elevated during pregnancy and the puerperium due to the physiological state of hypercoagulability (increased clotting factors, decreased protein S, and venous stasis). A history of embolism in a previous puerperium is a major risk factor for recurrence. **Why Option B is Correct:** Warfarin is the anticoagulant of choice in the **postpartum period** (puerperium) because it is highly effective and, crucially, it is **not excreted in breast milk** in active amounts, making it safe for breastfeeding. In patients with a history of pregnancy-associated VTE, thromboprophylaxis is typically indicated for at least 6 weeks postpartum. **Analysis of Incorrect Options:** * **Option A:** Warfarin is **teratogenic** (Warfarin Embryopathy) between 6–12 weeks of gestation, causing nasal hypoplasia and skeletal abnormalities. It also crosses the placenta, risking fetal hemorrhage. Therefore, it is contraindicated during the first trimester and near term. * **Option C:** The risk of recurrence in a subsequent pregnancy after a single prior VTE is approximately **1–12%** (varying by study), but the statement "increases by 12%" is statistically imprecise compared to the definitive management step required. * **Option D:** Management is mandatory. A history of VTE requires a risk-stratified approach, usually involving Low Molecular Weight Heparin (LMWH) during pregnancy and switching to Warfarin or continuing LMWH postpartum. **Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) during pregnancy:** LMWH (e.g., Enoxaparin) is preferred as it does not cross the placenta. * **Warfarin Embryopathy:** Characterized by stippled epiphyses and midface hypoplasia. * **Highest Risk Period:** The risk of VTE is highest during the **first 3 weeks postpartum**, though prophylaxis is generally continued for 6 weeks. * **Heparin Monitoring:** LMWH does not require routine PT/INR monitoring; if needed, Anti-Xa levels are measured.
Explanation: **Explanation:** The clinical presentation of fever (≥100.4°F), a soft (subinvoluted) uterus, and exquisite uterine tenderness in the early postpartum period is the classic triad of **Postpartum Endometritis**. **1. Why Endometritis is correct:** Endometritis is the most common cause of puerperal febrile morbidity. It involves infection of the decidua (endometrium) and occasionally the underlying myometrium. **Cesarean section** is the single most significant risk factor, increasing the risk 10- to 20-fold compared to vaginal delivery. The "soft and tender" uterus indicates that the infection is interfering with normal uterine involution. **2. Why other options are incorrect:** * **Vaginitis:** Typically presents with discharge, itching, or local irritation, but does not cause high-grade fever or systemic uterine tenderness. * **Parametritis:** This involves infection of the pelvic connective tissue (parametrium), usually spreading laterally from the uterus. While it causes fever, it typically presents with lateral pelvic pain and a "woody" or fixed sensation on bimanual exam, rather than isolated uterine tenderness. * **Salpingitis:** While it can occur as a complication of puerperal sepsis, isolated salpingitis is rare in the early postpartum period because the fallopian tubes are usually protected by the physiological barriers of the healing uterus. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Treatment:** Intravenous **Clindamycin + Gentamicin** (covers anaerobes and gram-negatives). * **Most Common Organisms:** Polymicrobial (Group B Streptococcus, *E. coli*, and anaerobes like *Bacteroides*). * **Timing:** Most cases occur within the first 2–10 days postpartum. Fever within the first 24 hours post-C-section is often due to atelectasis or early-onset streptococcal infection.
Explanation: **Explanation:** The clinical presentation of fever and breast tenderness two weeks postpartum is diagnostic of **Lactational Mastitis**. **1. Why Dicloxacillin is correct:** The most common causative organism for mastitis is ***Staphylococcus aureus*** (often originating from the infant's nasopharynx). **Dicloxacillin** is a penicillinase-resistant penicillin, making it the drug of choice because it specifically targets beta-lactamase-producing Staphylococci. It is safe during breastfeeding and provides excellent coverage for the most likely pathogen. **2. Why the other options are incorrect:** * **Ampicillin:** While safe, it is susceptible to degradation by beta-lactamase. Most *S. aureus* strains are now resistant to plain ampicillin. * **Ceftazidime:** This is a third-generation cephalosporin primarily used for Gram-negative infections (including *Pseudomonas*). It is overkill for simple mastitis and lacks optimal Gram-positive coverage compared to dicloxacillin. * **Ciprofloxacin:** Fluoroquinolones are generally avoided as first-line agents in breastfeeding mothers due to theoretical concerns regarding infant cartilage development. **Clinical Pearls for NEET-PG:** * **Management:** The most important step in managing mastitis is **continued breastfeeding** or regular pumping to prevent milk stasis and abscess formation. * **Abscess:** If a fluctuant mass develops or the fever doesn't subside within 48-72 hours of antibiotics, suspect a **Breast Abscess**. The gold standard treatment is **Incision and Drainage (I&D)** or ultrasound-guided needle aspiration. * **MRSA:** If MRSA is suspected, Clindamycin or Trimethoprim-sulfamethoxazole (TMP-SMX) are preferred alternatives.
Explanation: **Explanation:** The clinical presentation of delayed postpartum hemorrhage (PPH) associated with an **isolated prolongation of APTT** (with normal PT, BT, and platelet count) is a classic hallmark of **Acquired Hemophilia A (AHA)**. **1. Why Acquired Hemophilia A is correct:** AHA is a rare but life-threatening autoimmune disorder caused by the development of autoantibodies (inhibitors) against Factor VIII. It has a bimodal age distribution, with one peak occurring in women during the postpartum period (usually within 1–4 months, but can occur within days). Because only Factor VIII is affected, the intrinsic pathway is disrupted, leading to a prolonged APTT, while the extrinsic pathway (PT) and primary hemostasis (Platelets/BT) remain unaffected. **2. Why the other options are incorrect:** * **Lupus Anticoagulant:** While it prolongs APTT, it is clinically associated with **thrombosis** (pro-thrombotic state) rather than active mucosal or postpartum bleeding. * **DIC:** This is a consumptive coagulopathy. You would expect **abnormalities in all parameters**: prolonged PT/APTT, decreased platelet count, and decreased fibrinogen. * **Inherited Congenital Hemophilia:** This is an X-linked recessive disorder that almost exclusively affects **males**. A 26-year-old female presenting with a new-onset bleeding disorder is highly unlikely to have a congenital form. **Clinical Pearls for NEET-PG:** * **Mixing Study:** In AHA, the prolonged APTT **does not correct** upon mixing the patient's plasma with normal plasma (distinguishes it from simple factor deficiency). * **Treatment:** Management involves bypassing agents (e.g., Recombinant Factor VIIa or Activated Prothrombin Complex Concentrate) and immunosuppression (steroids/cyclophosphamide) to eliminate the inhibitor. * **High-Yield Association:** Postpartum state is the most common "trigger" for AHA in young women.
Explanation: ### Explanation **Puerperal sepsis** is defined as an infection of the genital tract occurring at any time between the onset of rupture of membranes or labor and the 42nd day postpartum. **Why Direct Extension is Correct:** The most common and primary mode of spread in puerperal sepsis is **direct extension** (also known as contiguous spread). Following delivery, the placental site is a raw, large wound with open venous sinuses, and the entire decidua is vulnerable. Bacteria (most commonly *Group A Streptococcus*, *E. coli*, or *Staphylococcus*) colonize the cervix or vagina and ascend to the endometrium (**Endometritis**). From there, the infection spreads directly to the myometrium (**Metritis**), the fallopian tubes (**Salpingitis**), and eventually the pelvic peritoneum (**Peritonitis**). **Analysis of Incorrect Options:** * **Aerial:** While airborne droplets can introduce bacteria into the birth canal (e.g., from the respiratory tract of healthcare workers), this is the *source* of contamination, not the *route of spread* within the pelvic organs. * **Venous:** Spread via the veins leads to **Pelvic Thrombophlebitis**. While a serious complication, it is a secondary pathway rather than the primary route for initial sepsis. * **Lymphatics:** Lymphatic spread typically leads to **Parametritis** (pelvic cellulitis). While common in cervical lacerations, it is less frequent than direct mucosal and tissue extension in generalized puerperal sepsis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common organism:** *Streptococcus pyogenes* (historically), but currently, polymicrobial infections (anaerobes + aerobes) are most frequent. * **Risk Factors:** Frequent vaginal examinations, prolonged rupture of membranes (PROM), and Cesarean section (the most significant risk factor). * **Clinical Triad:** Fever (>38°C/100.4°F), foul-smelling lochia, and uterine tenderness. * **Management:** The gold standard is intravenous **Clindamycin and Gentamicin**.
Explanation: **Explanation:** The patient presents with classic signs of **Lactational Mastitis** (fever, unilateral breast pain, erythema, and warmth), likely secondary to nipple trauma (cracked nipple) and milk stasis. **1. Why Option A is Correct:** The cornerstone of mastitis management is **effective milk drainage**. Continuing breastfeeding from both breasts—including the affected side—prevents further milk stasis, which is the primary driver of the infection. Frequent emptying reduces the risk of the condition progressing to a breast abscess. The milk is safe for the infant as the source of infection is typically the infant’s own nasopharynx (e.g., *Staphylococcus aureus*). **2. Why Other Options are Incorrect:** * **Option B:** Stopping breastfeeding on the affected side worsens milk stasis, significantly increasing the risk of **breast abscess** formation. * **Option C:** While antibiotics (e.g., Dicloxacillin or Cephalexin) are indicated, breastfeeding should **not** be discontinued. Most first-line antibiotics for mastitis are compatible with breastfeeding. * **Option D:** "Pump and discard" is unnecessary. The infant can safely consume the milk, and direct breastfeeding provides more efficient drainage than most pumps. **Clinical Pearls for NEET-PG:** * **Most Common Organism:** *Staphylococcus aureus*. * **First-line Treatment:** Frequent nursing/emptying + Analgesics (NSAIDs) + Antibiotics (Dicloxacillin/Flucloxacillin). * **Mastitis vs. Abscess:** If a tender, **fluctuant** mass is present, suspect an abscess. Diagnosis is confirmed via Ultrasound, and management requires **Incision and Drainage (I&D)** or needle aspiration. * **Key Advice:** Always check the infant's latch, as poor positioning is the most common cause of nipple trauma leading to mastitis.
Explanation: **Explanation:** The primary goal of administering Anti-D immunoglobulin (RhoGAM) is to prevent **Rh isoimmunization** in an Rh-negative mother carrying an Rh-positive fetus. During delivery, fetal red blood cells enter the maternal circulation (fetomaternal hemorrhage). If the mother is not sensitized, her immune system will produce antibodies against the D-antigen, risking Hemolytic Disease of the Fetus and Newborn (HDFN) in subsequent pregnancies. **Why 72 hours is the correct answer:** Clinical studies have established that Anti-D is most effective when administered as soon as possible after potential exposure. The **72-hour window** is the standard gold-reaching recommendation because it effectively clears fetal RBCs before the maternal primary immune response is fully primed. However, it is important to note that if the 72-hour window is missed, it should still be given up to 13–28 days postpartum, though with reduced efficacy. **Analysis of Incorrect Options:** * **A & B (6 and 24 hours):** While administration within this timeframe is ideal and highly effective, it is not the "limit" defined by standard protocols. * **D (7 days):** Waiting 7 days significantly increases the risk that maternal sensitization has already begun, making the immunoglobulin less effective at preventing future alloimmunization. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Dose:** 300 mcg (1500 IU) is given intramuscularly following a full-term delivery. This dose covers up to 30 ml of fetal whole blood (or 15 ml of fetal RBCs). * **Kleihaur-Betke Test:** Used to quantify the volume of fetomaternal hemorrhage to determine if additional doses of Anti-D are required. * **Antenatal Prophylaxis:** Routinely given at **28 weeks** gestation to all non-sensitized Rh-negative women. * **Other Indications:** Anti-D must also be given after abortion, ectopic pregnancy, amniocentesis, or external cephalic version.
Explanation: **Explanation:** The **placental site** is the most common site of puerperal infection (puerperal sepsis). Following the delivery of the placenta, the site remains a raw, denuded area with open venous sinuses and clotted blood. This environment acts as an ideal culture medium for bacteria. The infection typically begins as **endometritis**, where organisms (most commonly *Group B Streptococcus* or anaerobes) colonize the placental site and rapidly spread to the rest of the decidua. **Analysis of Options:** * **Placental Site (Correct):** It is the primary focus of infection because it lacks a protective epithelial lining immediately after birth, allowing direct access for ascending vaginal flora into the uterine wall and circulation. * **Cervical Laceration:** While these can become infected, they are less common than endometritis. They usually present as localized cervicitis unless the infection spreads to the parametrium. * **Episiotomy Wound:** This is a common site for *localized* infection (vulvitis), but in the context of systemic puerperal sepsis, the uterine cavity (starting at the placental site) is statistically more frequent. * **Vaginal Laceration:** Similar to episiotomies, these are secondary sites. While they can lead to localized abscesses, they are not the primary origin for the majority of puerperal febrile morbidity. **High-Yield Clinical Pearls for NEET-PG:** * **Definition:** Puerperal pyrexia is defined as a temperature of **38.0°C (100.4°F)** or higher on any two of the first 10 days postpartum (excluding the first 24 hours). * **Most Common Organism:** *Streptococcus pyogenes* (historically) and *Staphylococcus aureus*; however, most infections are **polymicrobial**. * **Risk Factor:** **Cesarean section** is the single most important risk factor for postpartum uterine infection. * **Gold Standard Treatment:** Clindamycin + Gentamicin (covers anaerobes and Gram-negative aerobes).
Explanation: **Explanation:** Lactation is a complex physiological process divided into four distinct stages. Understanding the terminology is crucial for NEET-PG, as these terms are frequently tested. **1. Why "Ejection of milk" is correct:** **Galactokinesis** refers to the discharge or ejection of milk from the mammary alveoli into the ducts and then out through the nipple. This process is primarily mediated by the **"Let-down reflex."** When the infant suckles, it triggers the release of **Oxytocin** from the posterior pituitary. Oxytocin causes the contraction of myoepithelial cells surrounding the alveoli, forcing milk out. **2. Why the other options are incorrect:** * **Synthesis of milk (Mammogenesis/Lactogenesis I):** This refers to the structural development of the mammary glands and the initial biochemical changes to produce milk components. * **Secretion of milk (Lactogenesis II):** This is the onset of copious milk secretion following delivery, triggered by the sudden withdrawal of estrogen and progesterone and the action of **Prolactin**. * **Sustaining lactation (Galactopoiesis):** This refers to the maintenance of established lactation. It requires a continuous supply of Prolactin (stimulated by regular suckling) and the periodic emptying of the breasts. **High-Yield Clinical Pearls for NEET-PG:** * **Prolactin** = Milk **Production** (Anterior Pituitary). * **Oxytocin** = Milk **Ejection** (Posterior Pituitary). * **Galactopoiesis** is maintained by the **suckling reflex**; if the breast is not emptied, the Feedback Inhibitor of Lactation (FIL) peptide accumulates, stopping further production. * **Bromocriptine** (Dopamine agonist) is the drug of choice to suppress lactation if medically indicated.
Normal Puerperium
Practice Questions
Lactation and Breastfeeding
Practice Questions
Postpartum Complications
Practice Questions
Postpartum Depression and Psychiatric Disorders
Practice Questions
Contraception After Delivery
Practice Questions
Postpartum Infections
Practice Questions
Secondary Postpartum Hemorrhage
Practice Questions
Recovery After Cesarean Delivery
Practice Questions
Postpartum Exercise and Rehabilitation
Practice Questions
Follow-up and Future Pregnancy Planning
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free